UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000008720
Receipt No. R000010230
Official scientific title of the study Reserch for clinical indicatior of pathophisiology of classic asthma and cough variant asthma -remission after inhaled corticosteroid treatment in cough variant asthma-
Date of disclosure of the study information 2012/08/24
Last modified on 2018/08/24 (Ver. 12)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Reserch for clinical indicatior of pathophisiology of classic asthma and cough variant asthma -remission after inhaled corticosteroid treatment in cough variant asthma-
Title of the study (Brief title) remission of cough variant asthma
Region
Japan

Condition
Condition cough variant asthma
Classification by specialty
Pneumology Adult
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 to clarify the proportion of remission in cough variant asthma
Basic objectives2 Others
Basic objectives -Others pathophysiology
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes the proportion of remission and recurrence in cough variant asthma
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
12 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria cough variant asthma
Key exclusion criteria chronic obstructive pulmonary desease,interstitial pneumonia,lung cancer,pulmonary tuberculosis,
bacterial pneumonia
Target sample size 20

Research contact person
Name of lead principal investigator Hisako Matsumoto
Organization Graduate School of Medicine, Kyoto University
Division name Respiratory Medicine
Address 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
TEL 075-751-3830
Email hmatsumo@kuhp.kyoto-u.ac.jp

Public contact
Name of contact person Tadao Nagasaki
Organization Graduate School of Medicine, Kyoto University
Division name Respiratory Medicine
Address 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, Japan
TEL 075-751-3830
Homepage URL
Email nagasaki@kuhp.kyoto-u.ac.jp

Sponsor
Institute Kyoto University
Institute
Department

Funding Source
Organization scholarship
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs YES
Study ID_1 E1225
Org. issuing International ID_1 Ethics Committee of Kyoto University
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 08 Month 24 Day

Progress
Recruitment status Terminated
Date of protocol fixation
2012 Year 08 Month 18 Day
Anticipated trial start date
2012 Year 08 Month 18 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information to investigate changes in hyperresponsiveness after inhaled corticosteroid cessation in cough variant asthma

Management information
Registered date
2012 Year 08 Month 18 Day
Last modified on
2018 Year 08 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000010230